6-Methyl-2-pyridinecarboximidamide was used as a reactant in the preparation of pyrimidine derivatives as ALK-5 inhibitors useful in mono- and combination treatment of diseases.
Leblanc, Catherine, et al.: Novartis AG, WO 2008006583 A1 20080117 (2008)